Holland & Knight Advises Riccobene Associates Family Dentistry in Sale to Comvest Private Equity
NASHVILLE (November 15, 2024) – Holland & Knight advised Riccobene Associates Family Dentistry, a portfolio company of New York-based private equity firm The Beekman Group and an affiliate of Beekman Investment Partners III, in its sale to Comvest Private Equity. The deal was announced on November 5.
In 2018, Beekman partnered with Dr. Michael Riccobene, DDS to form a dental service organization to support Dr. Riccobene's dental group Riccobene Associates Family Dentistry, originally founded in 2000. Riccobene Associates Family Dentistry, operated by BAF Management Services, LLC through its subsidiaries and affiliates, is one of the largest dental service organizations in the Southeast Region with over 60 locations in North Carolina, South Carolina and Virginia.
Headquartered in West Palm Beach, Fla., Comvest Private Equity is the private equity strategy of Comvest Partners, a private investment firm providing equity and debt capital to middle-market companies across North America.
Holland & Knight's representation of Riccobene Associates Family Dentistry was led by Partners Eric Scalzo and Joshua Porte. They were assisted by Partners Mark Miller and Daniel Patten, and Associates Nimroz Ali, Jacob Bolton and Forrest Tinnin.
Holland & Knight attorneys have been important counselors to Dr. Michael Riccobene, DDS and the dental support organization Riccobene Associates Family Dentistry since before its partnership with Beekman in 2018. The team has assisted the company in its growth, regulatory compliance and provided legal advice on day-to-day operational matters.
More information on the transaction can be found here.
Recently recognized as the Private Equity Law Firm of the Year by the Global M&A Network, Holland & Knight regularly ranks among the leading M&A and private equity law firms in reputable, benchmarking league tables published by Bloomberg, LSEG, Mergermarket, PitchBook and The Deal. The firm is also ranked the most active law firm in the country for healthcare private equity transactions through the first half of 2024. Through the HK Deal Flow℠ program, Holland & Knight facilitates deal leads for clients and prospective clients by matching acquisition or capital raising opportunities with buyers and investors.